Theravance Biopharma Inc (0TB) — Cash Flow Quality Index
Theravance Biopharma Inc (0TB) has a Cash Flow Quality Index of -1.80x as of September 2025. Operating cash flow of €-6.51 Million is below net income of €3.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Theravance Biopharma Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Theravance Biopharma Inc Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Theravance Biopharma Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Theravance Biopharma Inc (0TB) cash conversion ratio.
Annual Cash Flow Quality Index for Theravance Biopharma Inc (2022–2022)
Year-by-year earnings quality comparison for Theravance Biopharma Inc.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -0.21x | €-186.99 Million | €872.13 Million | — |